BD INSULIN SYRINGE— 510(k) K024112
Substantially EquivalentBecton, Dickinson & CO
FDA 510(k) clearance K024112 for BD INSULIN SYRINGE, Substantially Equivalent on 2003-01-09. Applicant: Becton, Dickinson & CO. Device class: 2.
Clearance details
- Applicant
- Becton, Dickinson & CO
- Product code
- Code FMF
- Device class
- Class 2
- Regulation
- 21 CFR 880.5860
- Advisory panel
- General Hospital
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Special
- Location
- Franklin Lakes, NJ, US
Recent devices under product code FMF
view allMore clearances from Becton, Dickinson & CO
view all- K160164 — BD Veritor System for Rapid Detection of Flu A + B Labratory Kit
- K160161 — BD Veritor System for Rapid Detection of Flu A + B CLIA waived kit
- K141474 — BECTON DICKINSON INTELLIPORT SYSTEM
- K140446 — BD PROBETEC CHLAMYDIA TRACHOMATIS (CT) QX AMPLIFIED DNA ASSAY
- K140448 — BD PROBETEC NEISSERIA GONORRHOEAE (GC) QX AMPLIFIED DNA ASSAY
Adverse events under product code FMF
product code FMF- Death
- 15
- Injury
- 2,263
- Malfunction
- 29,722
- Other
- 17
- Total
- 32,017
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Recalls naming K024112
K-number listed on FDA's recall recordMatched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K024112.
Data sourced from openFDA. This site is unofficial and independent of the FDA.